Background illustration for clinical trials search

Paid Clinical Trials Chicago

Discover 2,374 paid clinical trials in Chicago, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

A Study of Brenipatide in Participants With Opioid Use Disorder

for
Opioid Use Disorder
Location: Chicago IL, Indianapolis IN, Columbus OH, Lexington KY,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07420283

Phase2, Recruiting
Active & Responsive

A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder

for
Alcohol Use Disorder
Location: Chicago IL, Middleburg Heights OH, Sioux Falls SD,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07219966

Phase3, Recruiting
Active & Responsive

Effect of Neural Constraints on Movement in Stroke

for
Stroke
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18 - 70+

Code: NCT06666673

Early_phase1, Recruiting
Active & Responsive

STRIVE Post-Market Registry Study

for
Emphysema
Location: Chicago IL, Anderson SC, Hershey PA, Baltimore MD,
Sponsor: Olympus Corporation of the Americas

Sex: All

Age: 18+

Code: NCT04302272

Recruiting
Active & Responsive

Emotional Well-being and Measures of Healthy Aging

for
Aging, Aging, Healthy, Aging Well, Aging, Biological
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 40 - 70

Code: NCT07334106

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy

for
Autoimmune Disorders
Location: Chicago IL, Rochester MN, Baltimore MD, Houston TX
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18+

Code: NCT07103746

Phase2, Recruiting
Active & Responsive

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: Chicago IL, Madison WI, Indianapolis IN, Ann Arbor MI,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06982521

Phase3, Recruiting
Active & Responsive

A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)

for
Extensive Stage-small Cell Lung Cancer
Location: Chicago IL, Milwaukee WI, Rochester MN, Minneapolis MN,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06362252

Phase1, Phase2, Recruiting
Active & Responsive

A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

for
Huntington Disease
Location: Chicago IL, Madison WI, Grand Rapids MI,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 21 - 70

Code: NCT07326709

Phase3, Recruiting
Active & Responsive

Mechanical Alignment vs Kalipered Kinematic Alignment Total Knee Arthroplasty

for
Knee Osteoarthritis, Knee Arthropathy
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 21 - 70+

Code: NCT06617871

Recruiting
Active & Responsive

Aromatherapy and Music Impact on Nurses' Stress at Work

for
Stress
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT07732179

Recruiting
Active & Responsive

Treatment of Moderate to Severe Refractory Crohn's Disease

for
Crohns Disease
Location: Chicago IL, Ann Arbor MI, Iowa City IA, St Louis MO,
Sponsor: Tr1X, Inc.

Sex: All

Age: 18 - 65

Code: NCT06721962

Phase1, Phase2, Recruiting
Active & Responsive

Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study

for
Prostate Carcinoma
Location: Chicago IL, Philadelphia PA, Boston MA, Duarte CA,
Sponsor: University of Washington

Sex: Male

Age: 40+

Code: NCT04472338

Recruiting
Active & Responsive

Increasing Germline Genetic Testing for Patients With Cancer

for
Hereditary Pancreatic Cancer, Conditions or Focus of Study,
Location: Chicago IL, Indianapolis IN, Nashville TN, Danville PA,
Sponsor: Josh Peterson

Sex: All

Age: 0+

Code: NCT07307664

Recruiting
Active & Responsive

Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis

for
Multiple Sclerosis,
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18 - 70

Code: NCT07225361

Recruiting
Active & Responsive

A Post-Market Assessment of the Safety and Performance of the TriClip™ System

for
Tricuspid Regurgitation (TR)
Location: Chicago IL, Austin TX
Sponsor: Abbott Medical Devices

Sex: All

Age: 18+

Code: NCT07586995

Recruiting
Active & Responsive

Cytokine Response to Abdominal Wall Reconstruction

for
Incisional Ventral Hernia
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT07422584

Recruiting
Active & Responsive

REgulatory T Cell Therapy to Achieve Immunosuppression REduction

for
Kidney Transplantation
Location: Chicago IL, Rochester MN, Phoenix AZ
Sponsor: Singulera Therapeutics Inc.

Sex: All

Age: 18 - 65

Code: NCT06552169

Phase2, Recruiting
Active & Responsive

Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD

for
ESRD (End-Stage Renal Disease), Kidney Transplantation,
Location: Chicago IL, New York NY
Sponsor: United Therapeutics

Sex: All

Age: 40 - 70

Code: NCT06878560

Phase1, Phase2, Recruiting
Active & Responsive

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer,
Location: Chicago IL, Indianapolis IN, Ann Arbor MI, Iowa City IA,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT06901531

Phase3, Recruiting

Chicago is a vital city for clinical research, offering a robust healthcare network and renowned medical research institutions. Major facilities such as The University of Chicago Medicine, Northwestern Medicine, and Rush University Medical Center are at the forefront of pioneering research across various fields, including cancer, cardiovascular health, and neurological disorders.

Why choose Chicago for clinical trials?

The city of Chicago offers many advantages for individuals considering participation in clinical trials. With a diverse and vibrant population, researchers benefit from the variety of participants, improving the reliability and applicability of research findings across different demographics.

By opting to participate in a clinical trial in Chicago, individuals not only gain access to cutting-edge therapies and treatments but also contribute to vital medical research. This collaborative effort is supported by a robust clinical research infrastructure, ensuring participants receive high-quality care and attention while playing a crucial role in shaping the future of healthcare.

Common conditions studied in Chicago

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Chicago